Rombauts, Alexander
Abelenda-Alonso, Gabriela
Simonetti, Antonella Francesca
Verdejo, Guillermo
Meije, Yolanda
Ortega, Lucia
Clemente, Mercedes
Niubó, Jordi
Ruiz, Yolanda
Gudiol, Carlota
Tebé, Cristian
Videla, Sebastian
Carratalà, Jordi
Funding for this research was provided by:
Instituto de Salud Carlos III (PI17/01332)
Article History
Received: 23 October 2019
Accepted: 26 July 2020
First Online: 20 August 2020
Ethics approval and consent to participate
: Ethical approval was obtained by the Clinical Research Ethics Committee of Bellvitge (reference number HUB-INF-ALBUCAP-402) and the Spanish Medicines and Medical Devices Agency (AEMPS) and is valid for all participating centers (all within in the same autonomous community). Informed consent will be obtained from all patients or their next of kin by the principal investigators. The study will be carried out in accordance with current Spanish (Real Decreto 1090/2015) and European legislation (Regulation 536/2014) and will follow the principles of the Helsinki Declaration (ISO 14155:2011).
: Not applicable
: The authors declare that they have no conflicts of interest.